Trial intelligence / Profile preview

Bile Acids and Energy Metabolism in Healthy Volunteers

NCT00706381Phase 3Completed

Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases
Start
Jun 2008
Primary completion
Aug 2012
Modality
Modified Peptides, Orthosteric Ligands, Native Peptides
Countries
1
01

Overview

A Phase 3 trial of ursodeoxycholic acid, sincalide in obesity, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Jun 2008; status: completed.

02

Drugs

ursodeoxycholic acidsincalide
03

Conditions

obesity

Beyond the preview

Go deeper on NCT00706381.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00706381.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call